The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer-Reference-Cited by-同舟云学术

The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer

Published:2017-07-13 Issue:11 Volume:31 Page:4682-4696
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Hormaechea‐Agulla Daniel¹²³⁴⁵,Jiménez‐Vacas Juan M.¹²³⁴⁵,Gómez‐Gómez Enrique¹²³⁶,López Fernando L.‐¹²³⁴⁵,Carrasco‐Valiente Julia¹³⁶,Valero‐Rosa José¹³⁶,Moreno María M.¹³⁷,Sánchez‐Sánchez Rafael¹³⁷,Ortega‐Salas Rosa¹³⁷,Gracia‐Navarro Francisco¹²³⁴⁵,Culler Michael D.⁸,Ibáñez‐Costa Alejandro¹²³⁴⁵,Gahete Manuel D.¹²³⁴⁵,Requena María J.¹³⁶,Castaño Justo P.¹²³⁴⁵,Luque Raúl M.¹²³⁴⁵

Affiliation:

1. Maimonides Institute of Biomedical Research of Córdoba (IMIBIC) Cordoba Spain

2. Department of Cell Biology, Physiology, and ImmunologyUniversity of Córdoba Cordoba Spain

3. Hospital Universitario Reina Sofía (HURS) Cordoba Spain

4. Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición(CIBERobn) Cordoba Spain

5. Campus de Excelencia Internacional Agroalimentario (CEIA3) Cordoba Spain

6. Urology ServiceHURS/IMIBIC Cordoba Spain

7. Anatomical Pathology ServiceHURS Cordoba Spain

8. Ipsen Bioscience Cambridge Massachusetts USA

Funder

European Commission

Ministerio de Economía y Competitividad